Hammond and colleagues used proteomics and SILAC phosphoproteomics to investigate the effects of KRAS common mutations, including G12D vs. G12V or G12D vs. G13D on KRAS signaling in isogenic human SW48 CRC cell-lines [87]. The gene discussed is KRAS; the disease is colorectal carcinoma.